Grant Bishop

Tuesday, 10 November 2026 · Markets closed · Edition 20

The Index › Metabolic medicine › Whose sales may the drugs shrink?

General Mills

GIS

General Mills sells packaged cereals, snacks and pet food under brands such as Cheerios and Nature Valley. We follow it because its sales depend on eating habits that weight-loss drugs and health trends may change.

Checked against the company's own business description in its latest annual filing. · entry updated 2026-10-19
Ticker
GIS
Exchange
—
Price
—
Change
—
As of
—
Market cap
—
EV/EBIT
—
P/E NTM
—
FCF yield
—
Net debt/EBITDA
—
Next earnings
—

Last refreshed from 10-Q filed (EDGAR)

Follow · Add to calendar · Daily window

The living report

Bears on our standing view that AI's economy-wide productivity lift does not arrive before 2028. It is proved wrong if productivity jumps much sooner than we expect, or adoption stops spreading.

last revised 19 Oct 2026 · next scheduled disclosure not yet announced
The full report

Members: queues this company for a report on a coming night.

The market record

Free during the preview. Each figure shows only where two independent data providers, Massive and Yahoo, agree on it to the cent; a figure they do not agree on is left out. Dated, not live. It describes; it does not recommend.

Last close$35.51
close of 6 Nov 2026 · Massive and Yahoo agree
The day's range$34.95 – $35.93
6 Nov 2026 · both providers agree
52-week range$31.18 – $49.59
intraday low 1 Oct 2026 · intraday high 12 Feb 2026 · 251 sessions to 6 Nov 2026 · both providers agree
Market value$19.0 billion
the 6 Nov 2026 close × 534,687,144 shares outstanding on the 10-Q cover, as of 16 Sep 2026
$

Enter any price. The page shows the multiple on the forward estimate on file and where that price sits in the 52-week range. It computes; it does not recommend.

Filings

Newest first, from EDGAR. Where a piece read a filing, one line of what it said.

2 Oct 20268-K · period ending 29 Sep 2026
30 Sep 20268-K · period ending 29 Sep 2026
23 Sep 202610-Q · period ending 30 Aug 2026
23 Sep 20268-K · period ending 23 Sep 2026
1 Jul 202610-K · period ending 31 May 2026
1 Jul 20268-K · period ending 1 Jul 2026
6 May 20268-K · period ending 4 May 2026
4 May 20268-K · period ending 4 May 2026
16 Apr 20268-K · period ending 16 Apr 2026
18 Mar 202610-Q · period ending 22 Feb 2026
18 Mar 20268-K · period ending 18 Mar 2026
27 Jan 20268-K · period ending 26 Jan 2026
17 Dec 202510-Q · period ending 23 Nov 2025
17 Dec 20258-K · period ending 17 Dec 2025
3 Oct 20258-K · period ending 30 Sep 2025
1 Oct 20258-K · period ending 25 Sep 2025
17 Sep 202510-Q · period ending 24 Aug 2025
17 Sep 20258-K · period ending 17 Sep 2025
26 Jun 202510-K · period ending 25 May 2025
25 Jun 20258-K · period ending 25 Jun 2025
27 May 20258-K · period ending 20 May 2025
19 May 20258-K · period ending 19 May 2025
17 Apr 20258-K · period ending 17 Apr 2025
19 Mar 202510-Q · period ending 23 Feb 2025
19 Mar 20258-K · period ending 19 Mar 2025
5 Mar 20258-K · period ending 2 Mar 2025
4 Feb 20258-K · period ending 30 Jan 2025
18 Dec 202410-Q · period ending 24 Nov 2024
18 Dec 20248-K · period ending 18 Dec 2024
21 Nov 20248-K · period ending 21 Nov 2024
15 Nov 20248-K · period ending 14 Nov 2024

Where it sits in the frame

Reports next

not yet announced

Latest disclosed

10-Q · filed 2026-09-23 · period ending 2026-08-30

Read the filing

Machine-readable

/index/GIS.json

What it has disclosed

Newest first. Every figure traces to a filing; "Show sources" shows which.

—No figure from this company appears in a committed piece yet.

Mentioned in

Every piece that names this company, newest first: what it said, and the standing view it bore on. Written when the piece is committed; never edited, never removed.

—No piece names this company yet.

Same question

Other companies under Whose sales may the drugs shrink?

This entry

19 Oct 2026Entry rewritten in plain words: what the company sells, and why we follow it.
12 Oct 2026Verified against the 10-Q filed 2026-09-23 at launch.

Prices on this page are dated market records, shown free during the preview, each confirmed by two independent data providers. None is a recommendation.

Follow General Mills. The weekly piece, and a note when a filing moves it.

Record

Written according to the Grant Bishop standard — machine-researched, machine-checked, human-judged; then read and committed by the publisher. Every number traces to a filing or a dated market record; every claim carries a date and what would prove it wrong.

Verification
multi-source verified, machine-drafted, human-gated
As of
2026-09-23
Position disclosure
The publisher holds index-level U.S. equity exposure and no direct position in any single name discussed.
Not advice
General commentary for a general audience. Not advice for your situation.
Sources (12)